State of Alaska Department of Revenue’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.1M | Sell |
56,418
-1,341
| -2% | -$112K | 0.05% | 332 |
|
|
2026
Q1 | $4.63M | Buy |
57,759
+60
| +0.1% | +$4.95K | 0.05% | 344 |
|
|
2025
Q4 | $4.92M | Sell |
57,699
-4,755
| -8% | -$390K | 0.05% | 316 |
|
|
2025
Q3 | $4.86M | Sell |
62,454
-3,385
| -5% | -$264K | 0.05% | 348 |
|
|
2025
Q2 | $5.15M | Sell |
65,839
-3,230
| -5% | -$241K | 0.06% | 321 |
|
|
2025
Q1 | $5.01M | Buy |
69,069
+1,827
| +3% | +$131K | 0.06% | 317 |
|
|
2024
Q4 | $4.98M | Sell |
67,242
-11,339
| -14% | -$794K | 0.06% | 318 |
|
|
2024
Q3 | $5.18M | Sell |
78,581
-5,305
| -6% | -$385K | 0.06% | 342 |
|
|
2024
Q2 | $7.75M | Buy |
83,886
+2,645
| +3% | +$234K | 0.09% | 217 |
|
|
2024
Q1 | $7.76M | Sell |
81,241
-5,000
| -6% | -$420K | 0.09% | 225 |
|
|
2023
Q4 | $6.58M | Sell |
86,241
-6,515
| -7% | -$453K | 0.08% | 279 |
|
|
2023
Q3 | $6.42M | Sell |
92,756
-2,530
| -3% | -$203K | 0.08% | 265 |
|
|
2023
Q2 | $8.99M | Buy |
95,286
+6,077
| +7% | +$528K | 0.11% | 194 |
|
|
2023
Q1 | $7.38M | Sell |
89,209
-1,392
| -2% | -$109K | 0.09% | 258 |
|
|
2022
Q4 | $6.76M | Sell |
90,601
-18,329
| -17% | -$1.41M | 0.08% | 279 |
|
|
2022
Q3 | $9M | Sell |
108,930
-4,477
| -4% | -$431K | 0.12% | 178 |
|
|
2022
Q2 | $10.8M | Sell |
113,407
-2,921
| -3% | -$302K | 0.13% | 162 |
|
|
2022
Q1 | $13.7M | Sell |
116,328
-3,540
| -3% | -$397K | 0.14% | 144 |
|
|
2021
Q4 | $15.5M | Buy |
119,868
+12,763
| +12% | +$1.49M | 0.15% | 133 |
|
|
2021
Q3 | $12.1M | Buy |
107,105
+1,610
| +2% | +$184K | 0.12% | 182 |
|
|
2021
Q2 | $10.9M | Sell |
105,495
-5,714
| -5% | -$539K | 0.11% | 217 |
|
|
2021
Q1 | $9.3M | Sell |
111,209
-8,180
| -7% | -$692K | 0.1% | 235 |
|
|
2020
Q4 | $10.9M | Sell |
119,389
-22,298
| -16% | -$1.85M | 0.12% | 194 |
|
|
2020
Q3 | $11.3M | Buy |
141,687
+2,673
| +2% | +$209K | 0.14% | 173 |
|
|
2020
Q2 | $9.61M | Sell |
139,014
-18,345
| -12% | -$1.3M | 0.12% | 213 |
|
|
2020
Q1 | $9.89M | Buy |
157,359
+9,120
| +6% | +$658K | 0.16% | 167 |
|
|
2019
Q4 | $11.5M | Sell |
148,239
-11,910
| -7% | -$930K | 0.15% | 169 |
|
|
2019
Q3 | $11.7M | Buy |
160,149
+60,906
| +61% | +$4.28M | 0.16% | 159 |
|
|
2019
Q2 | $6.11M | Buy |
99,243
+546
| +0.6% | +$33K | 0.1% | 231 |
|
|
2019
Q1 | $6.29M | Sell |
98,697
-4,440
| -4% | -$253K | 0.11% | 213 |
|
|
2018
Q4 | $5.26M | Sell |
103,137
-5,184
| -5% | -$262K | 0.1% | 223 |
|
|
2018
Q3 | $6.29M | Sell |
108,321
-204
| -0.2% | -$9.98K | 0.11% | 214 |
|
|
2018
Q2 | $5.26M | Buy |
108,525
+24,330
| +29% | +$1.14M | 0.09% | 236 |
|
|
2018
Q1 | $3.92M | Buy |
84,195
+10,320
| +14% | +$448K | 0.08% | 288 |
|
|
2017
Q4 | $2.77M | Buy |
73,875
+58,380
| +377% | +$2.14M | 0.07% | 342 |
|
|
2017
Q3 | $564K | Buy |
+15,495
| New | +$591K | 0.03% | 663 |
|
|
2017
Q2 | – | Sell |
-9,564
| Closed | -$299K | – | 1226 |
|
|
2017
Q1 | $299K | Buy |
+9,564
| New | +$299K | 0.02% | 497 |
|
Other funds holding EW
WT
State of Alaska Department of Revenue's EW Position: Q2 2026 in Review
State of Alaska Department of Revenue reduced its Edwards Lifesciences (EW) stake by 2.3% in Q2 2026, selling an estimated $112K and leaving 56,418 shares worth $5.1M. The position accounts for 0.05% of the portfolio, ranked #332.
State of Alaska Department of Revenue first reported a position in EW in Q1 2017 and has held it in 37 quarters since. The position peaked at $15.5M in Q4 2021. 973 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- State of Alaska Department of Revenue held 56,418 shares of Edwards Lifesciences worth $5.1M as of Q2 2026.
- State of Alaska Department of Revenue sold 1,341 Edwards Lifesciences shares in Q2 2026, an estimated $112K.
- Edwards Lifesciences made up 0.05% of State of Alaska Department of Revenue's portfolio in Q2 2026, its #332 holding.
- State of Alaska Department of Revenue first reported a position in Edwards Lifesciences in Q1 2017 and has held it in 37 quarters since.
- State of Alaska Department of Revenue's Edwards Lifesciences position peaked at $15.5M in Q4 2021.
- 973 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on State of Alaska Department of Revenue's 13F filing for Q2 2026, filed 20 Jul 2026.